Schizophrenia and attendance in primary healthcare:a population-based matched cohort study by Nørgaard, H. C.B. et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Schizophrenia and attendance in primary healthcare
a population-based matched cohort study
Nørgaard, H. C.B.; Schou Pedersen, H.; Fenger-Grøn, M.; Vestergaard, M.; Nordentoft, M.;
Laursen, T. M.; Mors, O.
Published in:
Scandinavian Journal of Primary Health Care
DOI:
10.1080/02813432.2019.1639927
Publication date:
2019
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Nørgaard, H. C. B., Schou Pedersen, H., Fenger-Grøn, M., Vestergaard, M., Nordentoft, M., Laursen, T. M., &
Mors, O. (2019). Schizophrenia and attendance in primary healthcare: a population-based matched cohort
study. Scandinavian Journal of Primary Health Care, 37(3), 358-365.
https://doi.org/10.1080/02813432.2019.1639927
Download date: 06. May. 2020
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=ipri20
Scandinavian Journal of Primary Health Care
ISSN: 0281-3432 (Print) 1502-7724 (Online) Journal homepage: https://www.tandfonline.com/loi/ipri20
Schizophrenia and attendance in primary
healthcare: a population-based matched cohort
study
H. C. B. Nørgaard, H. Schou Pedersen, M. Fenger-Grøn, M. Vestergaard, M.
Nordentoft, T. M. Laursen & O. Mors
To cite this article: H. C. B. Nørgaard, H. Schou Pedersen, M. Fenger-Grøn, M. Vestergaard, M.
Nordentoft, T. M. Laursen & O. Mors (2019) Schizophrenia and attendance in primary healthcare:
a population-based matched cohort study, Scandinavian Journal of Primary Health Care, 37:3,
358-365, DOI: 10.1080/02813432.2019.1639927
To link to this article:  https://doi.org/10.1080/02813432.2019.1639927
© 2019 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group.
Published online: 12 Jul 2019.
Submit your article to this journal 
Article views: 636
View related articles 
View Crossmark data
RESEARCH ARTICLE
Schizophrenia and attendance in primary healthcare: a population-based
matched cohort study
H. C. B. Nørgaarda,b , H. Schou Pedersenc, M. Fenger-Grønc, M. Vestergaardc, M. Nordentoftd,
T. M. Laursene and O. Morsa
aPsychosis Research Unit, Aarhus University Hospital, Risskov, Denmark; bDepartment of Clinical Medicine, Aarhus University, Aarhus
N, Denmark; cResearch Unit for General Practice & Section for General Medical Practice, Department of Public Health, Aarhus
University, Aarhus C, Denmark; dPsychiatric Center Copenhagen, University of Copenhagen, Hellerup, Denmark; eNational Centre for
Register-based Research, Aarhus BSS, Aarhus University, Aarhus C, Denmark
ABSTRACT
Objective: Schizophrenia is associated with high mortality, somatic comorbidity and reduced
life expectancy. The general practitioner (GP) plays a key role in the treatment of mental and
physical multimorbidity. Nevertheless, it is unclear how much individuals with schizophrenia use
primary healthcare. This study aims to investigate the yearly numbers of consultations in general
practice for individuals with schizophrenia.
Design and Setting: We performed a population-based matched cohort study of 21,757 individ-
uals with schizophrenia and 435,140 age- and gender-matched references from Danish National
Registers. Monthly general practice consultations were analysed using a generalized linear
model with log link and assuming negative binomial distribution.
Main outcome measures: Consultation rates in general practice up to17 years after index diagnosis.
Results: Individuals with schizophrenia attended their GP more than references throughout the
study period. The cases had 82% (95% CI: 78-87) and 76% (95% CI: 71-80) more consultations in
primary care after 1 year and 5 years, respectively. Individuals with both schizophrenia and
comorbid somatic illness attended even more.
Conclusion: Individuals with schizophrenia are in regular contact with their GP, especially if
they have comorbid illnesses. Whether an average of six consultations per year for individuals
with schizophrenia is sufficient is up for debate. The study demonstrates a potential for an
increased prevention and treatment of individuals with schizophrenia in general practice.
KEY POINTS
Schizophrenia is associated with high mortality, somatic comorbidity and reduced life expect-
ancy. Little is known about the attendance pattern in primary care for individuals with
schizophrenia.
 We found high attendance rates in primary care for individuals diagnosed with schizophrenia
from index diagnosis and at least 17 years after diagnosis, which suggests opportunities for
earlier intervention to improve their somatic health.
 We found an association between high illness comorbidity and increased risk of not attend-
ing the general practitioner. The most severely somatically and mentally ill individuals may
thus be difficult to reach and support in the current healthcare system.
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Introduction
Individuals with schizophrenia have a 15–20 years
reduced life expectancy compared to the general
population [1–3]. Schizophrenia is strongly associated
with a multifactorial higher risk of death [4–6].
Schizophrenia is characterized by both negative symp-
toms [loss of initiative, neglect of self-care] and psych-
otic symptoms, which often reduce social interaction.
These characteristics often lead to a sedentary lifestyle,
unhealthy diet and little exercising [7,8] and hence
also increased risk of developing lifestyle-associated
diseases. Furthermore, negative and psychotic symp-
toms can be barriers to seeking help and receiving
the correct medical treatment [9,10]. Less frequent
participation in screening [11] and undertreatment of
somatic illness [12] also contribute to the high
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mortality. General practitioners [GPs] play a crucial role
for individuals with multimorbidity as GPs are trained
in managing several concurrent medical conditions
[13]. Danish GPs handle a broad spectrum of illnesses
and serve as gatekeepers to secondary care [12]. Still,
individuals with schizophrenia are repeatedly hospital-
ised for preventable conditions [14]. It remains unclear
why individuals with schizophrenia are underdiag-
nosed and poorly treated for somatic illness. The pri-
mary healthcare system may play a role, but little is
known about the use of general practice.
We aimed to describe the primary healthcare util-
isation in Danish general practice for individuals with
incident schizophrenia and to evaluate whether cer-
tain groups of individuals are at higher risk of missing
out in general practice.
Materials and methods
Design
We conducted a population-based matched compara-
tive cohort study based on Danish nationwide registry
data. The Danish Civil Registration System (CRS) [15]
includes data for all Danish citizens on name, gender,
date of birth, place of birth, citizenship and identity of
parents. All records are continuously updated with
information on vital status, place of residence and
cohabitation status. This information can be linked
through the civil registration number (CRN), which is
assigned to all Danish citizens.
Study population
We identified cases in the Psychiatric Central Research
Register ([PCRR). We included all individuals aged
15–90 years diagnosed with schizophrenia in Denmark
from January 1998 to June 2014. For each case with
schizophrenia (ICD8 code 295 and ICD10 code F20) we
randomly sampled twenty age- and gender-matched
(± one month) individuals from the background popu-
lation as references. Prevalent cases from 1969 (the
year PCRR was established) until December 1997 were
censored to ensure that only incident cases with a
first-time diagnosis of schizophrenia were included.
Information on gender and age was obtained from
the CRS and information on migration was provided
by Statistics Denmark. Sampling was done without
replacement for each schizophrenia case but with
replacement between schizophrenia cases, i.e. each
person could serve as a reference for more than one
schizophrenia case but only once for the same schizo-
phrenia case. Also, reference persons could later be
included as a schizophrenia case if they were given
the diagnosis.
Index date
For individuals diagnosed as inpatients (i.e. admitted
to a psychiatric hospital immediately before first diag-
nosis of schizophrenia), the index date was defined as
the first date of discharge from hospital after the diag-
nosis of schizophrenia. For individuals diagnosed as
outpatients, the index date was defined as the first
visit in an outpatient clinic after the registration of
the diagnosis.
National registers
The PCRR holds information on all inpatient contacts
from 1969 and outpatient contacts from 1995, includ-
ing diagnosis, date of treatment initiation, type of
referral, place of treatment, municipality of residence
and mode of admission.
All services provided by Danish GPs are registered
prospectively in the Danish National Health Service
Registry (NHSR). This register holds information on all
contacts to general practice since 1990 [16]. Danish
GPs have approximately 1600 listed patients each,
including 4–7 individuals with schizophrenia. The
registrations in the NHSR are considered to be very
complete, as Danish GPs are paid on a tax-funded fee-
for-service basis, which requires each GP to register all
consultations to get reimbursed [16].
Information on all contacts to somatic hospital out-
patient clinics for both cases and references was
obtained from the Danish National Patient Register
(NPR); which holds information on somatic diagnoses
from 1977 and all somatic outpatient contacts from
1995 [17].
Socioeconomic status
Information on marital/partner status and education
status was obtained from Statistics Denmark and
Danish education registers [18,19]. Marital/partner sta-
tus was indexed as living with a partner (married, regis-
tered civil partnership or cohabiting) or living solitary.
The highest attained educational level was divided
into three categories based on the International
Standard Classification of Education (ISCED) developed
by the United Nations: low (<10 years), medium
(10–15 years) and high (>15 years) [20].
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE 359
Comorbidity
We obtained information on comorbidity using an ear-
lier developed algorithm with 39 categorised somatic
and mental disorders [21]. The disorders were identi-
fied by combining diagnosis codes (ICD10) with data
on redeemed prescriptions for medication from the
Register of Medicinal Product Statistics. We identified
the number of comorbid illnesses (0, 1, or 2 comor-
bid illnesses) and furthermore determined whether
cases and references had any of the four specified
somatic illnesses: diabetes mellitus, hypertension,
ischemic heart disease or lung disease (Tables 1–3). All
baseline characteristics were collected from registers
at the time of the index diagnosis and after five years.
Outcomes
Primary outcomes were consultations in general prac-
tice, daytime and out of hours. These were reported
from index date and the following 17 years graphically
and in absolute numbers one year and five years after
the index date and described with personal
characteristics.
Table 2. Daytime consultations in General Practice during 1st and 5th year after index date.
Subgroups 1st year (Sz) 1st year (Ref) 5th year (Sz) 5th year (Ref)
Mean annual No
Consultations
Mean annual No
Consultations
1st year
IRR (95% CI)
Mean annual No
Consultations
Mean annual No
Consultations
5th year
IRR (95% CI)
All 5.84 (5.70;5.98) 3.28 (3.27;3.30) 1.82 (1.78;1.87) 6.05 (5.90;6.20) 3.55 (3.53;3.56) 1.76 (1.71;1.80)
Male 4.66 (4.50;4.82) 2.36 (2.34;2.37) 1.97 (1.90;2.04) 4.56 (4.39;4.73) 2.59 (2.57;2.61) 1.79 (1.73;1.86)
Female 7.47 (7.23;7.71) 4.58 (4.55;4.60) 1.64 (1.59;1.70) 8.08 (7.82;8.35) 4.88 (4.85;4.91) 1.71 (1.65;1.77)
Education
<10 years (low) 6.15 (5.96;6.34) 3.63 (3.60;3.66) 1.75 (1.69;1.80) 6.31 (6.11;6.51) 4.03 (4.00;4.06) 1.64 (1.58;1.69)
10–15 years (medium) 5.26 (5.06;5.48) 3.09 (3.07;3.11) 1.69 (1.62;1.76) 5.59 (5.35;5.85) 3.30 (3.28;3.33) 1.68 (1.60;1.76)
>15 years (high) 5.46 (5.04;5.92) 2.98 (2.95;3.01) 1.79 (1.64;1.94) 5.78 (5.21;6.41) 3.10 (3.07;3.14) 1.85 (1.66;2.02)
Cohabitation
Single/living alone 5.60 (5.44;5.76) 3.07 (3.05;3.09) 1.80 (1.75;1.85) 5.72 (5.56;5.89) 3.38 (3.36;3.41) 1.67 (1.62;1.72)
Married/cohabitating 6.79 (6.54;7.06) 3.49 (3.47;3.51) 1.89 (1.82;1.97) 7.34 (7.00;7.70) 3.69 (3.66;3.71) 1.93 (1.84;2.03)
Comorbidity
Number of diseases
0 4.62 (4.50;4.74) 2.77 (2.76;2.78) 1.68 (1.63;1.72) 5.19 (5.04;5.35) 3.06 (3.04;3.07) 1.69 (1.64;1.74)
1 6.31 (6.01;6.61) 4.61 (4.57;4.66) 1.46 (1.38;1.53) 6.41 (6.10;6.73) 4.99 (4.93;5.05) 1.41 (1.33;1.49)
2 10.70 (10.10;11.33) 7.70 (7.57;7.84) 1.47 (1.38;1.57) 10.19 (9.53;10.90) 7.97 (7.85;8.10) 1.39 (1.29;1.49)
Somatic Diseases
Diabetes mellitus 11.69 (10.55;12.95) 7.37 (7.20;7.54) 1.65 (1.46;1.87) 10.97 (9.79;12.29) 7.44 (7.24;7.64) 1.50 (1.34;1.69)
Hypertension 10.55 (9.76;11.41) 6.76 (6.67;6.85) 1.67 (1.53;1.82) 9.98 (9.18;10.84) 7.05 (6.93;7.17) 1.54 (1.41;1.57)
Ischemic heart disease 10.35 (8.77;12.21) 7.10 (6.86;7.35) 1.52 (1.26;1.83) 11.35 (9.32;13.83) 7.27 (6.98;7.56) 1.64 (1.31;2.08)
Lung disease 11.78 (10.52;13.20) 5.85 (5.71;5.99) 2.03 (1.81;2.28) 11.16 (9.85;12.64) 5.86 (5.70;6.01) 1.93 (1.69;2.19)
IRR: incidence rate ratios; CI: confidence interval.
Sz: schizophrenia.
Ref: References.
Table 1. Cohort characteristics at baseline and five years after index date.
Measure
Baseline
Schizophrenia (N)
Baseline
References (N) p Value
5 years
Schizophrenia (N)
5 Years
References (N) p Value
Total 21,757 435,140 14,935 311,550
Male 12,687 (58%) 253,470 (58%) 8621 (58%) 181,249 (58%)
Female 9070 (42%) 181,400 (42%) 6314 (42%) 130,301 (42%)
Education
<10 years 13,834 (64%) 169,750 (39%) <0.001 8969 (60%) 85,777 (28%) <0.001
10–15 years 6415 (29%) 200,669 (46%) <0.001 4834 (32%) 162,717 (52%) <0.001
>15 years 1508 (7%) 64,721 (15%) <0.001 1132 (8%) 63,056 (20%) <0.001
Single/living alone 17,483 (81%) 215,221 (49%) <0.001 11,820 (79%) 117,670 (38%) <0.001
Married/ cohabitating 4265 (19%) 219,684 (51%) <0.001 3071 (21%) 192,595 (62%) <0.001
Comorbidity
Number of diseases
0 13,361 (62%) 356,556 (82%) 8480 (57%) 238,576 (77%)
1 5557 (25%) 52,562 (12%) <0.001 3715 (25%) 45,486 (15%) <0.001
2 2839 (13%) 26,022 (6%) 2740 (18%) 27,488 (9%)
Somatic diseases
Diabetes mellitus 736 (3.4%) 8263 (1.9%) <0.001 848 (5.7%) 8304 (2.7%) <0.001
Hypertension 1221 (5.6%) 22,661 (5.2%) <0.001 1315 (8.8%) 23,825 (7.6%) <0.001
Ischemic heart disease 265 (1.2%) 3804 (0.90%) <0.001 259 (1.7%) 4041 (1.3%) <0.001
Lung diseases 620 (2.8%) 10,422 (2.4%) <0.001 558 (3.7%) 8526 (2.7%) <0.001

Of the 21.757 cases at baseline 1023 (4,7%) persons had died five years after index date, and 5799 persons did not obtain five years observation time.
Of the 435.140 references at baseline 5190 persons had died (1,2%).
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Secondary outcomes were number of different serv-
ices provided in general practice, e.g. blood sample
tests, rapid strep tests, and, spirometer tests.
Furthermore, we identified all patients with no GP
consultations in the first and fifth year of observation.
Finally, we examined the proportion of non-attenders
in two settings: GP visit and GP visit plus somatic out-
patient contact in secondary health care.
Statistical methods
Individuals contributed with risk time from the index
date and until the date of death or the end of the
study period (June 2014), whichever came first. During
follow-up, individuals were censored if hospitalized
(somatic or psychiatric); they re-entered the study after
hospital discharge. Individuals who emigrated were
censored and re-entered the study after immigration
to Denmark.
The number of consultations was analysed using a
generalized linear model with a log link and assuming
negative binomial distributed counts. These models
yielded incidence rate ratios (IRRs). All analyses were
adjusted for age, sex and calendar time. To account
for heterogeneity between individuals in strata, we
applied cluster robust variance estimation. The loga-
rithm of risk time was used as offset. We analysed
the number of face-to-face consultations (daytime,
out-of-hours and both combined) and the number of
diagnostic tests taken in different time periods. The
follow-up period was divided into 1st month, 2nd
month, 3rd month, 4th–5th month, 6th–11th month,
12th–17th month, 18th–23rd month, 3rd year, 4th
year, 5th–6th year, 7th–12th year, and 13th–17th year
after index date. The number of face-to-face consulta-
tions was also analysed for 1st and 5th observation
year, and the consultations were stratified on pre-
specified variables.
The dichotomous outcome of non-attendance was
analysed using a binomial model with a log link. The
probability pij 2 0; 1½  of non-attendance for individual
i in period j was modelled as pij ¼ exp Xi  BijTtij
 
;
where tij 2 0; 1½  denotes the risk time for individual i
in period j, Xi denotes the matrix with 1 in the first col-
umn and the baseline values for the different variables
used in the regression in the other columns, and Bij
denotes the corresponding coefficient matrix. Non-
attendance was analysed for 1st and 5th observation
year and was stratified on pre-specified variables. In a
sensitivity analysis, we also included contacts to som-
atic outpatient clinics. Chi square tests were applied to
test for differences in the baseline characteristics. Two-
sided significance tests were performed for all analyses
at 5% significance level.
Results
The study included 21,757 individuals with schizophre-
nia (cases) and 435,140 age- and gender-matched
references without schizophrenia (references). Cases
and references had an average age of 34,6 years at
index date.
Over all cases had more daytime and out-of-hours
consultations in general practice than references
(Figure 1), particularly during the first month after
index date. During the first month cases had 95%
Table 3. Relative Risk and Proportion of no GP consultations during 1st and 5th years after index date.
F2F contacts
1st year after
index date
Proportion
year 1
Proportion
year 1
5th year after
index date
Proportion
year 5
Proportion
year 5
Baseline variables RR (95% CI) Reference Schizophrenia RR (95% CI) Reference Schizophrenia
All 0.68 (0.66;0.70) 24.18 20.77 0.79 (0.76;0.82) 24.57 21.17
Male 0.66 (0.64;0.69) 32.01 26.06 0.78 (0.75;0.81) 32.32 27.50
Female 0.74 (0.69;0.79) 13.22 13.41 0.82 (0.75;0.89) 13.79 12.51
Education
<10 years (low) 0.67 (0.64;0.69) 22.94 19.72 0.80 (0.76;0.84) 22.85 20.52
10–15 years (medium) 0.74 (0.70;0.78) 24.62 21.99 0.84 (0.78;0.89) 25.10 21.95
>15 years (high) 0.81 (0.73;0.90) 26.03 25.13 0.82 (0.72;0.93) 27.24 23.44
Cohabitation
Single/living alone 0.66 (0.64;0.69) 26.29 22.30 0.77 (0.74;0.81) 26.61 22.75
Married/cohabitating 0.58 (0.53;0.63) 22.06 14.46 0.66 (0.59;0.73) 22.82 14.87
Comorbidity
Number of diseases
0 0.73 (0.71;0.76) 26.91 23.29 0.81 (0.78;0.85) 26.98 22.98
1 0.95 (0.88;1.02) 14.25 19.34 1.18 (1.09;1.28) 15.17 20.35
2 1.12 (0.96;1.31) 6.71 11.64 1.36 (1.14;1.62) 8.45 12.57
Somatic diseases
Diabetes mellitus 0.57 (0.39;0.83) 8.96 8.05 0.79 (0.51;1.22) 10.55 9.41
Hypertension 0.77 (0.59;1.01) 7.28 8.29 0.92 (0.68;1.24) 9.23 9.49
Ischemic heart disease 1.12 (0.71;1.76) 8.94 12.88 1.35 (0.80;2.27) 9.83 14.01
Lung disease 0.46 (0.40;0.84) 11.30 8.10 0.66 (0.45;0.97) 13.51 11.11

Face-to face contacts; RR: relative risk; CI: confidence interval.
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more daytime consultations, IRR ¼ 1.95 (95% CI:
1.88–2.03) this gradually decreased and settled at
approximately 65% more consultations from four
months after the index date and throughout the study
period (up to 17 years). The numbers of out-of-hour GP
services were 433% higher during the first month after
the index date, IRR ¼ 5.33 (95% CI: 4.69–6.05); then
decreased and settled at approximately 300% more
consultations for cases throughout the study period.
Cases had significantly more GP consultations than
references during the first and the fifth observation
year, regardless of gender, education, cohabitation
and comorbidity. Cases had 82% (95% CI: 78–87) more
consultations than references after one year and 76%
(95% CI: 71–80) more after five years (6.05 vs. 3.55
annual consultations) (Table 2). After the first year,
cases without any comorbidity had 68% more consul-
tations in general practice, IRR ¼ 1.68 (95% CI:
1.63–1.72), than references. This was significantly
higher than the corresponding IRRs for cases and
references with one comorbid illness, IRR ¼ 1.46 (95%
CI: 1.38–1.53), or two or more comorbid illness, IRR ¼
1.47(95% CI: 1.38–1.57).
At baseline and five years after index date, cases
had a higher risk (38% and 43%) than references (18%
and 25%) of having comorbid disorders (Table 1).
Cases had more consultations coded as; talk ther-
apy, ECGs, blood tests and pulmonary tests. The

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Figure 1. General practice daytime and Out-of-Hours consultations comparing patients with schizophrenia with the background
population 1st and 5th years after index date.
Figure 2. Services provided in general practice comparing patients with schizophrenia with the background population.
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number of performed haemoglobin level tests, urine
stix tests and C-reactive protein tests were similar to
the number for references, whereas fewer rapid strep
tests were registered for cases (Figure 2).
Cases showed a lower probability of having no con-
sultations to general practice after one year, relative
risk (RR) ¼ 0.68 (95% CI: 0.66–0.70), and five years,
RR ¼ 0.79 (95% CI: 0.76–0.82) (Table 3).
When stratified for; comorbid illnesses plus schizo-
phrenia predicted a trend towards increasing likeli-
hood of having no consultations to general practice.
One year after the index date, the relative risk of hav-
ing no consultations to general practice was 0.95 (95%
CI: 0.88–1.02) for cases with one comorbid illness and
1.12 (95% CI: 0.96–1.31) for cases with for two or
more comorbid illnesses (Table 3). Five years after the
index diagnosis, the risk of having no consultations to
general practice was statistically significantly higher
for cases than for references (Table 3).
The sensitivity analysis showed a trend that cases
with no consultations to general practice had a higher
probability of having no somatic hospital outpatient
contacts in addition to increasing comorbidity; five
years after the index date, the cases had a significantly
higher relative risk of having no consultations than
the references (Data not shown).
Discussion
Principal findings
Cases had significantly more consultations to a general
practitioner both during daytime and in out-of-hours
consultations than references throughout the study
period, indicating that general practice could play an
important role in the identification and treatment of
mental and physical diseases for these patients. This
suggests that GPs are important healthcare professionals
to service this patient group. The attendance in out-of
hour’s services was particularly high for cases. This might
not be so surprising with sleep impairment and circa-
dian rhythm disturbances being a part of the schizo-
phrenia syndrome. As well as these patients having
difficulties planning their time or managing scheduled
appointments. Furthermore the majority of the total
consultations were daytime consultations demonstrated
by the more narrow confidence intervals (Figure 1).
The relative difference between cases and references
tended to decrease with increasing number of comor-
bidities. This may indicate that individuals with schizo-
phrenia generally receive insufficient care when they
have several somatic conditions or that the GP tends to
manage several conditions during the same visit.
Cases had lower educational level and greater risk
of comorbid illness and of living alone than references
at baseline. This could indicate poor health conditions
already from an early stage of their illness and outlines
the severe risk profile for these vulnerable individuals
as low educational level and solitary living is individual
risk factors for early death.
Individuals with schizophrenia are also having more
consultations in general practice before the diagnosis
of schizophrenia [22]. Nonetheless, an increasing num-
ber of post-diagnostic GP consultations is not surpris-
ing as nearly 40% of cases already at baseline had one
or more co-existing comorbid illnesses that require
attention in general practice (Table 1). We do not
know the exact reasons for the increased frequency of
GP consultations. The cases had more face-to-face
contact during daytime and out-of-hours care, but
they also received more talk therapy, ECGs, blood
tests, haemoglobin level measurements and pulmon-
ary tests in general practice (Figure 2). The GPs thus
managed many healthcare tasks, but for individuals
with high comorbidity and a severe mental illness, it
may be debatable whether the observed number of
six yearly consultations (Table 2) is sufficient.
For both cases and references, the proportion with
“no show” decreased with increasing numbers of
comorbid illnesses. Yet, this decrease was less marked
among cases, which left a trend of a higher risk of “no
show” in general practice for cases with comorbid ill-
ness than references with comparable comorbidity
both one year (11.64% versus 6.71% for persons with
two or more comorbid illnesses) and five years after
the index diagnosis (Table 3). Still, the cases censored
due to temporary hospitalisation were included in
these results. The relative risk of 1.12 (95% CI:
0.96–1.31) found in our models (Table 3) is thus likely
to be a more accurate estimate. Our results show a
trend, but these are not statistically significant one
year after the index date.
The most somatically vulnerable group of individu-
als with schizophrenia appear to have greater risk of
not attending their GP. This is a finding of concern as
it implies a lower likelihood of receiving proper care
for existing comorbid illnesses. We found an increased
likelihood of “no show” for both consultations at the
GP and at somatic hospital outpatient clinics with
increasing number of comorbid illnesses; these figures
were significant after five years (Data not shown). One
explanation could be that individuals with schizophre-
nia have limited resources to prioritise consultations
to healthcare professionals. The reduced visit rate in
general practice for a small proportion of the cases
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with several comorbid illnesses may thus strengthen
our hypothesis that somatic comorbid illnesses are
undertreated, and this could be one of the contribu-
tors to the premature death seen in these individuals.
Existing evidence
To our knowledge, this is the most comprehensive
study to investigate attendance patterns in general
practice for individuals with schizophrenia. Hetlevik
et al. found that most individuals diagnosed with
schizophrenia had regular contact with their GP, and
patients with diabetes, obstructive pulmonary disease,
or cardiovascular disease had more GP consultations
than controls [23]. Our findings are comparable for
regular GP contact, but our data showed that comorbid
illness in cases with schizophrenia lowered the IRR of
more GP consultations compared with references, which
could also increase the risk of not attending the GP.
Osborn et al. found that individuals with severe men-
tal illness (SMI) in British primary care were less likely to
be screened for cardiovascular disease than individuals
without SMI [24]. Smith et al. showed that individuals
with schizophrenia have higher probability of having
somatic comorbid illness and lower probability of hav-
ing cardiovascular disease recorded in their GP medical
record; this also suggests undertreatment of somatic
disease [25]. A similar pattern was found in a study of
540 primary care practices in London [26]. We actually
found a higher likelihood of ECG recording and blood
tests taken in cases than in references; this could indi-
cate a certain level of cardiovascular screening in
Danish primary care or at least an awareness of the
potential need for somatic screening.
Strengths and limitations
Our study has several strengths. Selection bias is
unlikely as we collected our data from Danish national
registries, and the cohort was followed virtually with-
out loss to follow-up. The data on consultations in
general practice were collected prospectively and
independently of the memory of patients, family
members and GPs, which eliminated the risk of recall
bias. The data from the NHSR are considered reliable,
as all Danish GPs must report all provided services in
this register to be reimbursed.
The study also has some limitations. The registers
do not hold information on consultation content or
the reason for making an appointment with the GP.
In the comparison of the consultation frequencies in
individuals with schizophrenia and the gender-, age- and
calendar time-matched reference population, it must be
kept in mind that these two groups differ in other
health-related aspects than the schizophrenia diagnosis.
For this reason, the raw frequency counts were supple-
mented by regression analyses in which the two groups
were compared under adjustment for gender, educa-
tional status, marital status and somatic comorbidities.
Nevertheless, other unmeasured confounders may have
affected the help-seeking pattern. The data did not allow
us to control for potential residual confounders, e.g.
severity of symptoms, relationship with the GP (who
may be affected by earlier forced hospitalizations) and
lifestyle (tobacco dependency, drug or alcohol abuse).
This could have affected our results.
As our findings are based on nationwide data from
a country with free and open access to general prac-
tice, they are generalizable to similar countries.
Clinical implications
Most persons living in Denmark with a schizophrenia
diagnosis attend their GP regularly after the initial diag-
nosis and continue to attend the GP, but undertreat-
ment of somatic illness is not solved with this alone.
Our results leave several questions unanswered:
Should individuals with schizophrenia have even more
GP consultations to ensure proper treatment of their
mental and somatic illnesses? Should they gain more
from the consultations? Schizophrenia is a risk factor
for more hospitalisations that probably could have
been prevented by proper care in primary care, which
supports the need for additional consultations or
greater benefit from GP consultations.
Our findings confirm that individuals with schizo-
phrenia remain in continuous attendance in general
practice from the prodromal phase and several years
after the first diagnosis. As nearly 40% have at least
one comorbid illness at the time of their index diag-
nosis of schizophrenia, the GP has a big responsibility
and many opportunities to improve the somatic
health in these individuals.
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